InspireMD Statistics
Total Valuation
InspireMD has a market cap or net worth of $58.82 million. The enterprise value is $25.79 million.
| Market Cap | 58.82M |
| Enterprise Value | 25.79M |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, before market open.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
InspireMD has 24.96 million shares outstanding. The number of shares has increased by 323.10% in one year.
| Shares Outstanding | 24.96M |
| Shares Change (YoY) | +323.10% |
| Shares Change (QoQ) | +41.10% |
| Owned by Insiders (%) | 17.36% |
| Owned by Institutions (%) | 48.08% |
| Float | 9.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 11.70 |
| PS Ratio | 9.08 |
| Forward PS | 7.19 |
| PB Ratio | 1.68 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.98 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.90, with a Debt / Equity ratio of 0.03.
| Current Ratio | 7.90 |
| Quick Ratio | 7.30 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -55.10% and return on invested capital (ROIC) is -67.15%.
| Return on Equity (ROE) | -55.10% |
| Return on Assets (ROA) | -47.00% |
| Return on Capital (ROIC) | -67.15% |
| Revenue Per Employee | $95,250 |
| Profits Per Employee | -$333,706 |
| Employee Count | 68 |
| Asset Turnover | 0.13 |
| Inventory Turnover | 2.34 |
Taxes
In the past 12 months, InspireMD has paid $65,000 in taxes.
| Income Tax | 65,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.33% in the last 52 weeks. The beta is 0.95, so InspireMD's price volatility has been similar to the market average.
| Beta (5Y) | 0.95 |
| 52-Week Price Change | -4.33% |
| 50-Day Moving Average | 2.37 |
| 200-Day Moving Average | 2.67 |
| Relative Strength Index (RSI) | 40.28 |
| Average Volume (20 Days) | 13,587 |
Short Selling Information
The latest short interest is 58,318, so 0.23% of the outstanding shares have been sold short.
| Short Interest | 58,318 |
| Short Previous Month | 71,216 |
| Short % of Shares Out | 0.23% |
| Short % of Float | 0.62% |
| Short Ratio (days to cover) | 2.86 |
Income Statement
In the last 12 months, InspireMD had revenue of $6.48 million and -$22.69 million in losses. Loss per share was -$0.73.
| Revenue | 6.48M |
| Gross Profit | 1.73M |
| Operating Income | -24.18M |
| Pretax Income | -22.63M |
| Net Income | -22.69M |
| EBITDA | -22.38M |
| EBIT | -22.63M |
| Loss Per Share | -$0.73 |
Balance Sheet
The company has $33.95 million in cash and $914,000 in debt, giving a net cash position of $33.04 million or $1.32 per share.
| Cash & Cash Equivalents | 33.95M |
| Total Debt | 914,000 |
| Net Cash | 33.04M |
| Net Cash Per Share | $1.32 |
| Equity (Book Value) | 35.09M |
| Book Value Per Share | 1.41 |
| Working Capital | 33.63M |
Cash Flow
In the last 12 months, operating cash flow was -$16.61 million and capital expenditures -$539,000, giving a free cash flow of -$17.15 million.
| Operating Cash Flow | -16.61M |
| Capital Expenditures | -539,000 |
| Free Cash Flow | -17.15M |
| FCF Per Share | -$0.50 |
Margins
Gross margin is 26.65%, with operating and profit margins of -373.26% and -350.35%.
| Gross Margin | 26.65% |
| Operating Margin | -373.26% |
| Pretax Margin | -349.34% |
| Profit Margin | -350.35% |
| EBITDA Margin | -345.55% |
| EBIT Margin | -349.34% |
| FCF Margin | -264.75% |
Dividends & Yields
InspireMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -323.10% |
| Shareholder Yield | -323.10% |
| Earnings Yield | -38.58% |
| FCF Yield | -29.15% |
Analyst Forecast
The average price target for InspireMD is $4.50, which is 85.19% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.50 |
| Price Target Difference | 85.19% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 67.99% |
| EPS Growth Forecast (5Y) | -16.54% |
Stock Splits
The last stock split was on April 27, 2021. It was a reverse split with a ratio of 1:15.
| Last Split Date | Apr 27, 2021 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
InspireMD has an Altman Z-Score of -3.19 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.19 |
| Piotroski F-Score | 4 |